Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events
- PMID: 17919564
- DOI: 10.1016/j.jacc.2007.06.040
Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events
Abstract
Objectives: We hypothesized that the expansion of unusual T lymphocytes, CD4+CD28null T cells, might represent a key pathogenetic mechanism of recurrent instability.
Background: Clinical presentation of acute coronary syndromes (ACS) is variable. Some patients have recurrent episodes of instability, despite optimal treatment, whereas others have a single acute event in their life. The CD4+CD28null T cells, with a functional profile that favors vascular injury, have recently been found both in peripheral blood and in unstable coronary plaques of patients with ACS.
Methods: Peripheral blood T cells from 120 consecutive unstable angina (UA) patients were analyzed for the distribution of T-cell subsets by flow cytometry. Patients were subgrouped according to the occurrence of prior (during the 24 months before the study enrollment) and subsequent (during the 24 months of follow-up) acute coronary events. For 51 patients, the index event was the first ever (G1); 30 patients had prior events (G2); and 39 patients had further events at follow-up (death, myocardial infarction, or UA) or both before and after the index event (G3).
Results: The CD4+CD28null T-cell frequency was higher in G3 than in G2 and G1 (median 9.5% [range 2.4% to 48.0%] vs. 5.1% [range 0.4% to 27.8%] and 2.3% [range 0.2% to 22.8%], respectively; p < 0.001). The expansion of these unusual T lymphocytes was higher in patients with elevated C-reactive protein levels, and it was reduced by statin therapy. On multivariate logistic regression analysis, CD4+CD28null T-cell frequency was an independent predictor of future acute coronary events (odds ratio 3.01, 95% confidence interval 1.1 to 8.25; p = 0.023).
Conclusions: A perturbation of T-cell repertoire is strongly associated with the recurrence of acute coronary events, conceivably playing a key pathogenetic role.
Comment in
-
T cells in coronary artery disease: different effects of different T-cell subsets.J Am Coll Cardiol. 2007 Oct 9;50(15):1459-61. doi: 10.1016/j.jacc.2007.06.041. Epub 2007 Sep 24. J Am Coll Cardiol. 2007. PMID: 17919565 No abstract available.
Similar articles
-
Modulation of CD4(+)CD28null T lymphocytes by tumor necrosis factor-alpha blockade in patients with unstable angina.Circulation. 2006 May 16;113(19):2272-7. doi: 10.1161/CIRCULATIONAHA.105.588533. Epub 2006 May 8. Circulation. 2006. PMID: 16682617
-
Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes.Circulation. 2004 Mar 16;109(10):1230-5. doi: 10.1161/01.CIR.0000118476.29352.2A. Epub 2004 Mar 1. Circulation. 2004. PMID: 14993140
-
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus.Eur Heart J. 2011 May;32(10):1214-26. doi: 10.1093/eurheartj/ehq499. Epub 2011 Jan 8. Eur Heart J. 2011. PMID: 21217142
-
C-reactive protein increase in unstable coronary disease cause or effect?J Am Coll Cardiol. 2005 Oct 18;46(8):1496-502. doi: 10.1016/j.jacc.2005.05.083. Epub 2005 Sep 28. J Am Coll Cardiol. 2005. PMID: 16226174 Review.
-
Redefining risk in acute coronary syndromes using molecular medicine.J Am Coll Cardiol. 2007 Jan 23;49(3):279-89. doi: 10.1016/j.jacc.2006.08.051. Epub 2007 Jan 4. J Am Coll Cardiol. 2007. PMID: 17239708 Review.
Cited by
-
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.Cells. 2023 May 2;12(9):1296. doi: 10.3390/cells12091296. Cells. 2023. PMID: 37174697 Free PMC article. Review.
-
Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes.Life (Basel). 2023 Apr 14;13(4):1010. doi: 10.3390/life13041010. Life (Basel). 2023. PMID: 37109539 Free PMC article. Review.
-
CD4+ T cells expressing CX3CR1, GPR56, with variable CD57 are associated with cardiometabolic diseases in persons with HIV.Front Immunol. 2023 Feb 14;14:1099356. doi: 10.3389/fimmu.2023.1099356. eCollection 2023. Front Immunol. 2023. PMID: 36865544 Free PMC article.
-
Bulk and single-cell characterisation of the immune heterogeneity of atherosclerosis identifies novel targets for immunotherapy.BMC Biol. 2023 Feb 28;21(1):46. doi: 10.1186/s12915-023-01540-2. BMC Biol. 2023. PMID: 36855107 Free PMC article.
-
The Role of BPIFB4 in Immune System and Cardiovascular Disease: The Lesson from Centenarians.Transl Med UniSa. 2021 Dec 23;24(1):1-12. doi: 10.37825/2239-9754.1029. eCollection 2021. Transl Med UniSa. 2021. PMID: 36447743 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
